• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CeriBell, Inc. - Common Stock (NQ:CBLL)

    24.83 +1.14 (+4.81%)
    Delayed Quote Updated: 2:46 PM EDT, Oct 5, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about CeriBell, Inc. - Common Stock

    < Previous 1 2 Next >
    News headline image
    Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis
    New clearance to further simplify bedside EEG interpretation and enable more informed interventions for patients of all ages across multiple indications 
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell Reports Second Quarter 2026 Financial Results
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review
    Neurology Review Software Enhancements Included as Part of Industry-Leading Ceribell Point-of-Care Brain Monitoring System 
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System
    Incremental NTAP Reimbursement Stands to Broaden Access to First-of-Its-Kind Dual Seizure and Delirium Monitoring Platform 
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe
    Medtech Market-Builder Thomas West and Health System Operator Sharon O’Keefe Join Ceribell as Point-of-Care Brain Monitoring Advances Toward Standard of Care 
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes
    Study published in leading critical care journal shows that higher AI-detected seizure burden is associated with increased odds of disability, further demonstrating the utility of the Ceribell System... 
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell Reports First Quarter 2026 Financial Results
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Participate in Upcoming March Investor Conferences
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution
    Clearance would position the Ceribell System as the first and only point-of-care electroencephalography (EEG) technology to aid in detection and monitoring of Large Vessel Occlusion (LVO) stroke in the... 
    From Ceribell
    Via GlobeNewswire
    News headline image
    AI Diagnostics: The End of the High-Cost Imaging Era
    Issued on behalf of VentriPoint Diagnostics Ltd. 
    From Equity Insider
    Via GlobeNewswire
    News headline image
    Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference
    From Ceribell
    Via GlobeNewswire
    News headline image
    Global AI Infrastructure Shift Ignites Biotech Growth Phase
    From USA News Group
    Via GlobeNewswire
    News headline image
    Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution
    Novel technology paves the way for use of the company's industry-leading point-of-care electroencephalography (EEG) system to address long unmet need in delirium monitoring 
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates
    Becomes the first and only FDA-cleared seizure detection algorithm for pre-term neonates through adults enabling rapid bedside detection, diagnosis, and treatment of non-convulsive seizures 
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell Reports Third Quarter 2025 Financial Results
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025
    From Ceribell
    Via GlobeNewswire
    News headline image
    Medtech Leader Erica Rogers Joins Ceribell Board of Directors
    Accomplished innovator and healthcare executive brings proven strategic leadership and expertise in scaling high-growth healthcare companies 
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell Reports Second Quarter 2025 Financial Results
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware
    Complaints Assert Infringement of Patents Related to Point-of-Care Electroencephalography (EEG) Technology 
    From Ceribell
    Via GlobeNewswire
    < Previous 1 2 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.